Evaxion Biotech A/S financial data

Symbol
EVAX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Dr Neergaards Vej 5 F, Hoersholm, Denmark
State of incorporation
Denmark
Fiscal year end
December 31
Latest financial report
20-F - Q4 2023 - Mar 26, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.9M shares +57%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 2.94M USD -28.6%
General And Administrative Expense 2.74M USD +27.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 12.9M USD -41.5%
Liabilities 17.6M USD +28.4%